Search

Search Constraints

You searched for: Author/Creator Amin, Janaki

Search Results

2. Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia. (1st October 2021)

3. Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy. (2nd November 2019)

4. Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection. Issue 1 (December 2016)

5. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. Issue 2 (February 2015)

6. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. Issue 1 (January 2017)

8. Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW). (19th August 2022)

9. Chronic hepatitis C burden and care cascade in Australia in the era of interferon‐based treatment. Issue 1 (January 2017)